Wedbush Securities Inc. Purchases 1,163 Shares of The Clorox Company $CLX

Wedbush Securities Inc. lifted its holdings in The Clorox Company (NYSE:CLX) by 15.5% during the second quarter, Holdings Channel reports. The institutional investor owned 8,654 shares of the company’s stock after acquiring an additional 1,163 shares during the quarter. Wedbush Securities Inc.’s holdings in Clorox were worth $1,039,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of CLX. American National Bank & Trust grew its holdings in Clorox by 69.5% in the second quarter. American National Bank & Trust now owns 217 shares of the company’s stock worth $26,000 after purchasing an additional 89 shares during the period. NewSquare Capital LLC lifted its holdings in shares of Clorox by 567.6% during the second quarter. NewSquare Capital LLC now owns 227 shares of the company’s stock valued at $27,000 after purchasing an additional 193 shares during the last quarter. Ransom Advisory Ltd purchased a new position in shares of Clorox during the first quarter valued at approximately $35,000. Hantz Financial Services Inc. bought a new stake in shares of Clorox in the 2nd quarter worth approximately $31,000. Finally, GW&K Investment Management LLC grew its stake in shares of Clorox by 239.1% in the 1st quarter. GW&K Investment Management LLC now owns 295 shares of the company’s stock worth $43,000 after buying an additional 208 shares during the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on CLX shares. Jefferies Financial Group reissued a “buy” rating and issued a $152.00 target price on shares of Clorox in a research note on Tuesday, November 4th. The Goldman Sachs Group reduced their price objective on shares of Clorox from $115.00 to $110.00 and set a “sell” rating for the company in a research note on Wednesday, October 1st. TD Cowen cut their price target on shares of Clorox from $120.00 to $117.00 and set a “hold” rating on the stock in a report on Wednesday, October 1st. Morgan Stanley reduced their target price on Clorox from $137.00 to $125.00 and set an “equal weight” rating for the company in a report on Tuesday, November 4th. Finally, BNP Paribas Exane lowered their price target on Clorox from $110.00 to $103.00 and set an “underperform” rating on the stock in a report on Tuesday, November 4th. One equities research analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and five have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Reduce” and an average target price of $125.69.

Insider Transactions at Clorox

In related news, COO Eric H. Reynolds sold 15,041 shares of the business’s stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the transaction, the chief operating officer directly owned 54,221 shares of the company’s stock, valued at approximately $6,711,475.38. The trade was a 21.72% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.63% of the company’s stock.

Clorox Price Performance

Shares of Clorox stock opened at $107.37 on Monday. The stock’s fifty day moving average is $119.49 and its 200 day moving average is $124.72. The Clorox Company has a one year low of $106.14 and a one year high of $171.37. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The stock has a market cap of $13.10 billion, a P/E ratio of 16.47, a P/E/G ratio of 0.92 and a beta of 0.52.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Monday, November 3rd. The company reported $0.85 earnings per share for the quarter, beating analysts’ consensus estimates of $0.78 by $0.07. The firm had revenue of $1.43 billion for the quarter, compared to analysts’ expectations of $1.41 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The business’s quarterly revenue was down 18.9% on a year-over-year basis. During the same period in the previous year, the firm earned $1.86 EPS. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. Sell-side analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd were given a $1.24 dividend. This represents a $4.96 annualized dividend and a dividend yield of 4.6%. The ex-dividend date was Wednesday, October 22nd. Clorox’s payout ratio is presently 77.86%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.